Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucy J Schmidt

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
The Journal of Steroid Biochemistry and Molecular Biology|October 2, 2010
Steroid 5 α-reductase inhibitors targeting BPH and prostate cancerLucy J Schmidt, Donald J Tindall
Current Drug Targets|April 10, 2013
Androgen receptor: past, present and futureLucy J Schmidt, Donald J Tindall
Journal of Andrology|October 13, 2004
Gene expression in prostate cancer cells treated with the dual 5 alpha-reductase inhibitor dutasterideLucy J Schmidt, Horacio Murillo, Donald J Tindall
The Prostate|May 5, 2007
Inhibition of fatty acid synthase activity in prostate cancer cells by dutasterideLucy J Schmidt, Karla V Ballman, Donald J Tindall
Cancer Research|October 18, 2002
p300 mediates androgen-independent transactivation of the androgen receptor by interleukin 6Jose D Debes, Lucy J Schmidt, Haojie Huang, et al.
Cancer Research|February 28, 2002
Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cellsOfelia L Zegarra-Moro, Lucy J Schmidt, Haojie Huang, et al.
Cancer Research|October 19, 2007
Selective role of an NH2-terminal WxxLF motif for aberrant androgen receptor activation in androgen depletion independent prostate cancer cellsScott M Dehm, Kevin M Regan, Lucy J Schmidt, et al.
Cancer Research|July 3, 2008
Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistanceScott M Dehm, Lucy J Schmidt, Hannelore V Heemers, et al.
Cancer Research|July 5, 2005
p300 regulates androgen receptor-independent expression of prostate-specific antigen in prostate cancer cells treated chronically with interleukin-6Jose D Debes, Barbara Comuzzi, Lucy J Schmidt, et al.
The Prostate|August 14, 2009
Effects of the 5 alpha-reductase inhibitor dutasteride on gene expression in prostate cancer xenograftsLucy J Schmidt, Kevin M Regan, S Keith Anderson, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
The Journal of Steroid Biochemistry and Molecular Biology|October 2, 2010
Steroid 5 α-reductase inhibitors targeting BPH and prostate cancerLucy J Schmidt, Donald J Tindall
Current Drug Targets|April 10, 2013
Androgen receptor: past, present and futureLucy J Schmidt, Donald J Tindall
Journal of Andrology|October 13, 2004
Gene expression in prostate cancer cells treated with the dual 5 alpha-reductase inhibitor dutasterideLucy J Schmidt, Horacio Murillo, Donald J Tindall
The Prostate|May 5, 2007
Inhibition of fatty acid synthase activity in prostate cancer cells by dutasterideLucy J Schmidt, Karla V Ballman, Donald J Tindall
Cancer Research|October 18, 2002
p300 mediates androgen-independent transactivation of the androgen receptor by interleukin 6Jose D Debes, Lucy J Schmidt, Haojie Huang, et al.
Cancer Research|February 28, 2002
Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cellsOfelia L Zegarra-Moro, Lucy J Schmidt, Haojie Huang, et al.
Cancer Research|October 19, 2007
Selective role of an NH2-terminal WxxLF motif for aberrant androgen receptor activation in androgen depletion independent prostate cancer cellsScott M Dehm, Kevin M Regan, Lucy J Schmidt, et al.
Cancer Research|July 3, 2008
Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistanceScott M Dehm, Lucy J Schmidt, Hannelore V Heemers, et al.
Cancer Research|July 5, 2005
p300 regulates androgen receptor-independent expression of prostate-specific antigen in prostate cancer cells treated chronically with interleukin-6Jose D Debes, Barbara Comuzzi, Lucy J Schmidt, et al.
The Prostate|August 14, 2009
Effects of the 5 alpha-reductase inhibitor dutasteride on gene expression in prostate cancer xenograftsLucy J Schmidt, Kevin M Regan, S Keith Anderson, et al.
Pageof 2